Tampa, Florida
Cancer biologic therapy trials in Tampa, FL
53 cancer biologic therapy studies are recruiting participants at sites in Tampa as of November 18, 2026, according to ClinicalTrials.gov. Cancer Biologic Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Tampa at a glance
- 53 studies are recruiting at a site in Tampa.
- By phase: Early Phase 1 (1), Phase 1 (8), Phase 1/2 (5), Phase 2 (19), Phase 2/3 (2), Phase 3 (18).
- By sponsor: industry (23), university, hospital or other (18), government (12).
- By research area: Lymphoma (18), Lung Cancer (16), Breast Cancer (12), Melanoma (4), Prostate Cancer (3).
- Most recent update to one of these records: November 18, 2026.
Breast cancer studies recruiting in Tampa
Basic details from each study's public record (the 30 most recently updated of 53). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Moffitt Cancer Center · Moffitt Cancer Center - McKinley Campus · Moffitt Cancer Center-International Plaza
- Registry record
- NCT03606967 · updated
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Saint Joseph's Hospital/Children's Hospital-Tampa
- Registry record
- NCT06058377 · updated
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Saint Joseph's Hospital/Children's Hospital-Tampa
- Registry record
- NCT06876714 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Tampa, FL on ClinicalTrials.gov.
Lung cancer studies recruiting in Tampa
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Moffitt Cancer Center · Moffitt Cancer Center - McKinley Campus · Moffitt Cancer Center-International Plaza
- Registry record
- NCT06498635 · updated
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Moffitt Cancer Center
- Registry record
- NCT04267848 · updated
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Phase 3
- Ages 70 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- James A. Haley Veterans Affairs Hospital · Moffitt Cancer Center · Moffitt Cancer Center - McKinley Campus
- Registry record
- NCT06096844 · updated
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Moffitt Cancer Center ( Site 0021)
- Registry record
- NCT07221474 · updated
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Obsidian Therapeutics, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06060613 · updated
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- CatalYm GmbH
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07098988 · updated
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Phase 2
- From 18 minutes
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06031688 · updated
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06616584 · updated
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- Florida Cancer Specialists
- Registry record
- NCT07222566 · updated
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Study site
- Moffitt Cancer Center
- Registry record
- NCT05681780 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Tampa, FL on ClinicalTrials.gov.
Prostate cancer studies recruiting in Tampa
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07164443 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Tampa, FL on ClinicalTrials.gov.
Melanoma studies recruiting in Tampa
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Immatics US, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06743126 · updated
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study sites
- Moffitt Cancer Center · Moffitt Cancer Center - McKinley Campus · Moffitt Cancer Center-International Plaza
- Registry record
- NCT04511013 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Tampa, FL on ClinicalTrials.gov.
Lymphoma studies recruiting in Tampa
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Phase 2
- Up to 365 days
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Saint Joseph's Hospital/Children's Hospital-Tampa
- Registry record
- NCT06317662 · updated
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Moffitt Cancer Center · Moffitt Cancer Center - McKinley Campus · Moffitt Cancer Center-International Plaza
- Registry record
- NCT06337318 · updated
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Tampa General Hospital ( Site 0134)
- Registry record
- NCT06717347 · updated
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 2
- Ages 1 to 30
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Saint Joseph's Hospital/Children's Hospital-Tampa · Tampa General Hospital
- Registry record
- NCT04546399 · updated
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- Phase 3
- Ages 5 to 60
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Saint Joseph's Hospital/Children's Hospital-Tampa · Tampa General Hospital
- Registry record
- NCT05675410 · updated
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07015242 · updated
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Lyell Immunopharma, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT07188558 · updated
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Allogene Therapeutics
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06500273 · updated
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 2
- From 366 days, up to 46 years
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Saint Joseph's Hospital/Children's Hospital-Tampa
- Registry record
- NCT06124157 · updated
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Moffitt Cancer Center
- Registry record
- NCT06015880 · updated
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Phase 2
- Ages 1 to 60
- All sexes
- Sponsor
- Fred Hutchinson Cancer Center
- Study site
- Moffitt Cancer Center
- Registry record
- NCT03970096 · updated
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Phase 1
- Ages 12 to 78
- All sexes
- Sponsor
- Orca Biosystems, Inc.
- Study site
- Moffitt Cancer Center
- Registry record
- NCT03802695 · updated
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Phase 2
- From 6 months
- All sexes
- Sponsor
- Allotera Therapeutics
- Study site
- H. Lee Moffitt Cancer Center and Research Institute Hospital
- Registry record
- NCT06514794 · updated
Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Study site
- Moffitt Cancer Center
- Registry record
- NCT05757219 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Tampa, FL on ClinicalTrials.gov.
Ask about studies near Tampa
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
126 studies recruiting across 65 cities.
Jacksonville
39 studies recruiting.
Miami
34 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.
Cancer Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections